The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is also highly problematic in lung infections, especially in people with the genetic disease cystic fibrosis7, chronic pulmonary disease8 and ventilator-associated pneumonia9.”
From Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility (2025) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
Research works printed but not linked: 40
- American Thoracic Society, 2005, Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia, Am J Respir Crit Care Med, 171, 388, 10.1164/rccm.200405-644ST · DOI · Paper page
- Esperatti, 2010, Nosocomial pneumonia in the intensive care unit acquired during mechanical ventilation or not, Am J Respir Crit Care Med, 182, 1533, 10.1164/rccm.201001-0094OC · DOI · Paper page
- Rosenthal, 2012, International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004–2009, Am J Infect Control, 40, 396, 10.1016/j.ajic.2011.05.020 · DOI · Paper page
- Micek, 2015, An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance, Crit Care, 19, 219, 10.1186/s13054-015-0926-5 · DOI · Paper page
- Tumbarello, 2013, Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients, Intensive Care Med, 39, 682, 10.1007/s00134-013-2828-9 · DOI · Paper page
- Alvarez-Lerma, 1996, Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-acquired Pneumonia Study Group, Intensive Care Med, 22, 387, 10.1007/BF01712153 · DOI · Paper page
- Kollef, 2014, Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa, Crit Care Med, 42, 2178, 10.1097/CCM.0000000000000510 · DOI · Paper page
- Fabregas, 1999, Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies, Thorax, 54, 867, 10.1136/thx.54.10.867 · DOI · Paper page
- Giunta, 2013, ICU-acquired pneumonia with or without etiologic diagnosis: a comparison of outcomes, Crit Care Med, 41, 2133, 10.1097/CCM.0b013e31828a453b · DOI
- Di Pasquale, 2014, Assessment of severity of ICU-acquired pneumonia and association with etiology, Crit Care Med, 42, 303, 10.1097/CCM.0b013e3182a272a2 · doi:10.1097/ccm.0b013e3182a272a2
- Ferrer, 2015, Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome, Crit Care, 19, 450, 10.1186/s13054-015-1165-5 · doi:10.1186/s13054-015-1165-5
- Heyland, 2008, Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia, Crit Care Med, 36, 737, 10.1097/01.CCM.0B013E31816203D6 · DOI · Paper page
- Martin-Loeches, 2015, J Infect, 70, 213, 10.1016/j.jinf.2014.10.004 · DOI
- Ioanas, 2004, Causes and predictors of non-response to treatment of the ICU-acquired pneumonia, Crit Care Med, 32, 938, 10.1097/01.CCM.0000114580.98396.91 · DOI
- Esperatti, 2013, Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU*, Crit Care Med, 41, 2151, 10.1097/CCM.0b013e31828a674a · DOI
- Luna, 2003, Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome, Crit Care Med, 31, 676, 10.1097/01.CCM.0000055380.86458.1E · DOI · Paper page
- Ranieri, 2012, Acute respiratory distress syndrome: the Berlin definition, JAMA, 307, 2526
- Ramirez, 2011, Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia, Crit Care Med, 39, 2211, 10.1097/CCM.0b013e3182257445 · DOI
- Bello, 2012, Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology, Eur Respir J, 39, 1144, 10.1183/09031936.00080411 · DOI
- Rello, 1993, Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia, Chest, 104, 1230, 10.1378/chest.104.4.1230 · DOI · Paper page
- Sandiumenge, 2011, Effect of antibiotic diversity on ventilator-associated pneumonia caused by ESKAPE organisms, Chest, 140, 643, 10.1378/chest.11-0462 · DOI
- Chung, 2011, High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia, Am J Respir Crit Care Med, 184, 1409, 10.1164/rccm.201102-0349OC · DOI · Paper page
- Parker, 2008, Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes, J Crit Care, 23, 18, 10.1016/j.jcrc.2008.02.001 · DOI
- Brusselaers, 2013, Value of lower respiratory tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: systematic review and diagnostic test accuracy meta-analysis, Intensive Care Med, 39, 365, 10.1007/s00134-012-2759-x · DOI
- Lopez-Ferraz, 2014, Impact of microbial ecology on accuracy of surveillance cultures to predict multidrug resistant microorganisms causing ventilator-associated pneumonia, J Infect, 69, 333, 10.1016/j.jinf.2014.05.011 · DOI
- Mandell, 2007, Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults, Clin Infect Dis, 44, S27, 10.1086/511159 · DOI · Paper page
- Trouillet, 2002, Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms, Clin Infect Dis, 34, 1047, 10.1086/339488 · DOI · Paper page
- El Amari, 2001, Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates, Clin Infect Dis, 33, 1859, 10.1086/324346 · DOI
- Jong, 1995, Rapidly fatal outcome of bacteremic Klebsiella pneumoniae pneumonia in alcoholics, Chest, 107, 214, 10.1378/chest.107.1.214 · DOI · Paper page
- Perlino, 1985, Alcoholism, leukopenia, and pneumococcal sepsis, Am Rev Respir Dis, 132, 757
- Palazzo, 2011, Biomarkers for ventilator-associated pneumonia: review of the literature, Heart Lung, 40, 293, 10.1016/j.hrtlng.2010.11.003 · DOI
- Micek, 2015, Pseudomonas aeruginosa nosocomial pneumonia: impact of pneumonia classification, Infect Control Hosp Epidemiol, 36, 1190, 10.1017/ice.2015.167 · DOI
- Makris, 2011, The impact of COPD on ICU mortality in patients with ventilator-associated pneumonia, Respir Med, 105, 1022, 10.1016/j.rmed.2011.03.001 · doi:10.1016/j.rmed.2011.03.001
- Rinaudo, 2015, Impact of chronic obstructive pulmonary disease in the outcome of intensive care unit-acquired pneumonia with and without previous intubation, Chest, 147, 1530, 10.1378/chest.14-2005 · DOI
- Cilloniz, 2016, Community-acquired pneumonia due to multidrug and non-multidrug resistant Pseudomonas aeruginosa, Chest, 150, 415, 10.1016/j.chest.2016.03.042 · DOI
- Martin-Loeches, 2013, Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors, Intensive Care Med, 39, 672, 10.1007/s00134-012-2808-5 · DOI
- Planquette, 2013, Pseudomonas aeruginosa ventilator-associated pneumonia. Predictive factors of treatment failure, Am J Respir Crit Care Med, 188, 69, 10.1164/rccm.201210-1897OC · DOI
- DiGiandomenico, 2014, A multifunctional bispecific antibody protects against Pseudomonas aeruginosa, Sci Transl Med, 6, 262ra155, 10.1126/scitranslmed.3009655 · DOI · Paper page
- Srinivas, 2010, Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa, Science, 327, 1010, 10.1126/science.1182749 · DOI · Paper page
- Koulenti, 2009, Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units, Crit Care Med, 37, 2360, 10.1097/CCM.0b013e3181a037ac · DOI · Paper page
Cited by
How to manage Pseudomonas aeruginosa infections
Bassetti, M., Vena, A., Croxatto, A., Righi, E., & Guery, B. (2018) · Drugs in Context · doi:10.7573/dic.212527 · Cited by 746
Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors
Jurado-Martín, I., Sainz-Mejías, M., & McClean, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063128 · Cited by 698
The environmental occurrence of Pseudomonas aeruginosa
Crone, S., Vives‐Flórez, M., Kvich, L., Saunders, A. M., Malone, M., Nicolaisen, M. H., Martínez‐García, E., Rojas‐Acosta, C., Catalina Gomez‐Puerto, M., Calum, H., et al. (2020) · APMIS · doi:10.1111/apm.13010 · Cited by 340
Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility
Letizia, M., Diggle, S. P., & Whiteley, M. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01193-8 · Cited by 231
Metadata
- Authors
- Fernández-Barat, L., Ferrer, M., De Rosa, F., Gabarrús, A., Esperatti, M., Terraneo, S., Rinaudo, M., Li Bassi, G., & Torres, A.
- Venue
- Journal of Infection
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 74
- Issue
- 2
- Pages
- 142-152
- ISSN
- 0163-4453
- Cited by
- 99
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance. https://app.cochat.ai/papers/10.1016/j.jinf.2016.11.008
- The paper
- Fernández-Barat, L., Ferrer, M., De Rosa, F., Gabarrús, A., Esperatti, M., Terraneo, S., Rinaudo, M., Li Bassi, G., & Torres, A. (2017). Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance. Journal of Infection. https://doi.org/10.1016/j.jinf.2016.11.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.